Management of recurrent hepatocellular carcinoma after liver transplant
about
Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer.Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation.Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation.
P2860
Management of recurrent hepatocellular carcinoma after liver transplant
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Management of recurrent hepatocellular carcinoma after liver transplant
@ast
Management of recurrent hepatocellular carcinoma after liver transplant
@en
Management of recurrent hepatocellular carcinoma after liver transplant
@nl
type
label
Management of recurrent hepatocellular carcinoma after liver transplant
@ast
Management of recurrent hepatocellular carcinoma after liver transplant
@en
Management of recurrent hepatocellular carcinoma after liver transplant
@nl
prefLabel
Management of recurrent hepatocellular carcinoma after liver transplant
@ast
Management of recurrent hepatocellular carcinoma after liver transplant
@en
Management of recurrent hepatocellular carcinoma after liver transplant
@nl
P2860
P356
P1476
Management of recurrent hepatocellular carcinoma after liver transplant
@en
P2860
P304
P356
10.4254/WJH.V7.I8.1142
P407
P577
2015-05-18T00:00:00Z